Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
36S3JAWr1YQznYVk
